Gloria Mattiuzzi

2.1k total citations
36 papers, 1.4k citations indexed

About

Gloria Mattiuzzi is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Gloria Mattiuzzi has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Epidemiology and 16 papers in Infectious Diseases. Recurrent topics in Gloria Mattiuzzi's work include Antifungal resistance and susceptibility (16 papers), Neutropenia and Cancer Infections (15 papers) and Fungal Infections and Studies (14 papers). Gloria Mattiuzzi is often cited by papers focused on Antifungal resistance and susceptibility (16 papers), Neutropenia and Cancer Infections (15 papers) and Fungal Infections and Studies (14 papers). Gloria Mattiuzzi collaborates with scholars based in United States, Germany and Argentina. Gloria Mattiuzzi's co-authors include Hagop M. Kantarjian, Luis Ostrosky‐Zeichner, John Rex, Richard J. Ridge, Zekaver Odabaşı, Paul A. Ketchum, Malcolm Finkelman, E Estey, Jörge E. Cortes and Francis J. Giles and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Gloria Mattiuzzi

36 papers receiving 1.4k citations

Peers

Gloria Mattiuzzi
Comparison fields: 5 of 98
  • Epidemiology 896
  • Infectious Diseases 882
  • Oncology 356
  • Pulmonary and Respiratory Medicine 187
  • Hematology 161
Replace Lambert F. R. Span with:
Lambert F. R. Span Netherlands
Gerda Silling Germany
Mabel Aoun Lebanon
V. A. Morrison United States
Gabriele Kropshofer Austria
Helen Leather United States
Angelika Böhme Germany
Z. Erjavec Netherlands
Nicole M. A. Blijlevens Netherlands
Martin Schmidt‐Hieber Germany
Lambert F. R. Span Netherlands View profile →
Citations per field, relative to Gloria Mattiuzzi
Gloria Mattiuzzi · 1×
Citations per year, relative to Gloria Mattiuzzi
Gloria Mattiuzzi · 1×

Countries citing papers authored by Gloria Mattiuzzi

Since Specialization
Citations

This map shows the geographic impact of Gloria Mattiuzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gloria Mattiuzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gloria Mattiuzzi more than expected).

Fields of papers citing papers by Gloria Mattiuzzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gloria Mattiuzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gloria Mattiuzzi. The network helps show where Gloria Mattiuzzi may publish in the future.

Co-authorship network of co-authors of Gloria Mattiuzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Gloria Mattiuzzi. A scholar is included among the top collaborators of Gloria Mattiuzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gloria Mattiuzzi. Gloria Mattiuzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia
2015 ·Journal of Infection and Chemotherapy ·Gloria Mattiuzzi, Musa Yılmaz, Hagop M. Kantarjian, Gautam Borthakur, Marina Konopleva, Elias Jabbour, (unknown), Sherry Pierce, Jörge E. Cortes
8
2
Phase II, Open Label, Randomized Comparative Trial of Ondansetron Alone versus the Combination of Ondansetron and Aprepitant for the Prevention of Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Regimens Containing High-Dose Cytarabine
2015 ·BioMed Research International ·Talha Badar, Jörge E. Cortes, Gautam Borthakur, Susan O’Brien, William G. Wierda, Guillermo Garcia‐Manero, Alessandra Ferrajoli, Tapan M. Kadia, (unknown), Hagop M. Kantarjian, Gloria Mattiuzzi
8
3
A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patients
2012 ·Leukemia ·Emil J. Freireich, Benjamin Lichtiger, Gloria Mattiuzzi, (unknown), (unknown), J. Kyle Wathen
8
4
Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma
2011 ·Cancer ·Maria E. Cabanillas, Hagop Kantarjian, Deborah A. Thomas, Gloria Mattiuzzi, Michael Rytting, Éduardo Bruera, Lianchun Xiao, B. Nebiyou Bekele, Maria Cielo Foudray, Jörge E. Cortes
19
5
Drug-Induced Nephrotoxicity Caused by Amphotericin B Lipid Complex and Liposomal Amphotericin B
2010 ·Medicine ·Amar Safdar, Jonathan Ma, (unknown), B. Dupont, John R. Wingard, Ray Hachem, Gloria Mattiuzzi, Pranatharthi Chandrasekar, Dimitrios P. Kontoyiannis, Kenneth V. I. Rolston, Thomas J. Walsh, Richard E. Champlin, Issam Raad
73
6
Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy‐induced nausea and vomiting in patients with acute myelogenous leukemia
2010 ·Cancer ·Gloria Mattiuzzi, Jörge E. Cortes, Deborah Blamble, B. Nebiyou Bekele, Lianchun Xiao, Maria E. Cabanillas, Gautam Borthakur, Susan O’Brien, Hagop M. Kantarjian
33
7
Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high‐risk myelodysplastic syndrome
2010 ·Cancer ·Amit Lahoti, Hagop M. Kantarjian, Abdulla K. Salahudeen, Farhad Ravandi, Jörge E. Cortes, Stefan Faderl, Susan O’Brien, William G. Wierda, Gloria Mattiuzzi
80
8
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome
2009 ·Supportive Care in Cancer ·Gloria Mattiuzzi, Jörge E. Cortes, Gladys Alvarado, Srđan Verstovšek, Charles Koller, Sherry Pierce, Deborah Blamble, Stefan Faderl, Lianchun Xiao, Mike Hernández, Hagop M. Kantarjian
42
9
Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high‐risk myelodysplastic syndrome
2009 ·Cancer ·(unknown), Charles Koller, Hagop M. Kantarjian, Farhad Ravandi, Srđan Verstovšek, Gautam Borthakur, Sherry Pierce, Gloria Mattiuzzi
18
10
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology
2009 ·European Journal of Cancer ·Georg Maschmeyer, T. Beinert, Dieter Buchheidt, Oliver A. Cornely, Hermann Einsele, Werner Heinz, Claus Peter Heußel, Christoph Kahl, Michael Kiehl, J. Lorenz, Herbert Hof, Gloria Mattiuzzi
73
11
Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction Therapy for Acute Myeloid Leukemia
2008 ·Journal of Clinical Oncology ·Alison Gardner, Gloria Mattiuzzi, Stefan Faderl, Gautam Borthakur, Guillermo Garcia‐Manero, Sherry Pierce, Mark Brandt, Elihu H. Estey
84
12
Neuraminidase Inhibitors Improve Outcome of Patients with Leukemia and Influenza: An Observational Study
2007 ·Clinical Infectious Diseases ·Roy F. Chemaly, Harrys A. Torres, Elizabeth Aguilera, Gloria Mattiuzzi, Maria E. Cabanillas, Hagop M. Kantarjian, Verónica González‐Calle, Amar Safdar, Issam Raad
37
13
Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia
2007 ·Haematologica ·Harrys A. Torres, Elizabeth Aguilera, Gloria Mattiuzzi, Maria E. Cabanillas, Nidhi Rohatgi, (unknown), H. Kantarjian, Ying Jiang, Amar Safdar, Issam Raad, Roy F. Chemaly
38
14
Patients with Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (HR-MDS) Treated with Targeted Therapy May Benefit from Prophylactic Measures Against Infections.
2006 ·Blood ·Gloria Mattiuzzi, Jörge E. Cortes, Stefan Faderl, Maria E. Cabanillas, Francis J. Giles, Susan O’Brien, Guillermo Garcia‐Manero, (unknown)
1
15
Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes
2005 ·Leukemia Research ·Francis J. Giles, Hagop M. Kantarjian, Jörge E. Cortes, S. Faderl, Srđan Verstovšek, Deborah A. Thomas, Guillermo Garcia‐Manero, William G. Wierda, Alessandra Ferrajoli, Stephen Kornblau, Gloria Mattiuzzi, Apostolia M. Tsimberidou, Maher Albitar, Susan O’Brien, Elihu H. Estey
10
16
Management of intracranial fungal infections in patients with haematological malignancies
2005 ·British Journal of Haematology ·Gloria Mattiuzzi, Francis J. Giles
37
17
Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy
2004 ·Cancer ·Gloria Mattiuzzi, Hagop M. Kantarjian, Stefan Faderl, JoAnn Lim, Dimitrios P. Kontoyiannis, Deborah A. Thomas, William G. Wierda, I. Raad, Guillermo Garcia‐Manero, Xian Zhou, (unknown), N. Bekele, Elihu H. Estey
30
18
Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high‐risk myelodysplastic syndrome undergoing induction chemotherapy
2004 ·Cancer ·Gloria Mattiuzzi, Hagop M. Kantarjian, Susan O’Brien, Dimitrios P. Kontoyiannis, Francis J. Giles, Xian Zhou, JoAnn Lim, B. Nebiyou Bekele, Stefan Faderl, Jörge E. Cortes, Sherry Pierce, G Leitz, Issam Raad, Elihu H. Estey
13
19
 -D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
2004 ·Clinical Infectious Diseases ·Zekaver Odabaşı, Gloria Mattiuzzi, E Estey, Hagop M. Kantarjian, (unknown), Richard J. Ridge, Paul A. Ketchum, Malcolm Finkelman, John Rex, Luis Ostrosky‐Zeichner
477
20
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction
2003 ·Cancer ·Gloria Mattiuzzi, Elihu H. Estey, Issam Raad, Francis J. Giles, Jörge E. Cortes, Yu Shen, Dimitrios P. Kontoyiannis, Charles Koller, Mark F. Munsell, Miloslav Beran, Hagop M. Kantarjian
62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lambert F. R. Span Breakdown of academic impact, for papers by Gerda Silling Breakdown of academic impact, for papers by Mabel Aoun Breakdown of academic impact, for papers by V. A. Morrison Breakdown of academic impact, for papers by Gabriele Kropshofer Breakdown of academic impact, for papers by Helen Leather Breakdown of academic impact, for papers by Angelika Böhme Breakdown of academic impact, for papers by Z. Erjavec Breakdown of academic impact, for papers by Nicole M. A. Blijlevens Breakdown of academic impact, for papers by Martin Schmidt‐Hieber
Rankless by CCL
2026